Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Lancet Respiratory Medicine,The - Tập 8 - Trang 475-481 - 2020
Xiaobo Yang1,2,3, Yuan Yu1,2, Jiqian Xu1,2, Huaqing Shu1,2, Jia'an Xia3, Hong Liu1,2,3, Yongran Wu1,2, Lu Zhang4, Zhui Yu5, Minghao Fang6, Ting Yu3, Yaxin Wang1,2, Shangwen Pan1,2, Xiaojing Zou1,2, Shiying Yuan1,2, You Shang1,2,3
1Department of Critical Care Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Institute of Anesthesiology and Critical Care Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3Jin Yin-tan Hospital, Wuhan, China
4Department of Critical Care Medicine, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Hubei, China
5Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China
6Union Hospital, and Department of Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Tài liệu tham khảo

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7 Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med, 10.1056/NEJMoa2001017 Holshue, 2020, First case of 2019 novel coronavirus in the United States, N Engl J Med, 10.1056/NEJMoa2001191 Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, 10.1001/jama.2020.1585 Dominguez-Cherit, 2009, Critically ill patients with 2009 influenza A(H1N1) in Mexico, JAMA, 302, 1880, 10.1001/jama.2009.1536 Fowler, 2003, Critically ill patients with severe acute respiratory syndrome, JAMA, 290, 367, 10.1001/jama.290.3.367 Kumar, 2009, Critically ill patients with 2009 influenza A(H1N1) infection in Canada, JAMA, 302, 1872, 10.1001/jama.2009.1496 Parry, 2020, Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city, BMJ, 368, m351, 10.1136/bmj.m351 Lew, 2003, Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome, JAMA, 290, 374, 10.1001/jama.290.3.374 Gomersall, 2004, Short-term outcome of critically ill patients with severe acute respiratory syndrome, Intensive Care Med, 30, 381, 10.1007/s00134-003-2143-y Arabi, 2014, Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection, Ann Intern Med, 160, 389, 10.7326/M13-2486 de Wit, 2016, SARS and MERS: recent insights into emerging coronaviruses, Nat Rev Microbiol, 14, 523, 10.1038/nrmicro.2016.81 Bellani, 2016, Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries, JAMA, 315, 788, 10.1001/jama.2016.0291 Rothe, 2020, Transmission of 2019-nCoV infection from an asymptomatic contact in Germany, N Engl J Med, 10.1056/NEJMc2001468 Gu, 2005, Multiple organ infection and the pathogenesis of SARS, J Exp Med, 202, 415, 10.1084/jem.20050828 Chu, 2016, Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways, J Infect Dis, 213, 904, 10.1093/infdis/jiv380 Liu, 2017, T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV, Antiviral Res, 137, 82, 10.1016/j.antiviral.2016.11.006 Liu, 2018, Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study, J Thorac Dis, 10, 5394, 10.21037/jtd.2018.08.137 Russell, 2020, Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury, Lancet, 395, 473, 10.1016/S0140-6736(20)30317-2